Baran Chemical and Pharmaceutical

Baran Chemical and Pharmaceutical is a prominent Iranian pharmaceutical company specializing in the development and production of high-tech active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). Established in 1995 and based in the Eshtehard Industrial Town, the company is a key subsidiary of the DAKPHA (Danesh Kimia Pharmed) Holding group. Baran is recognized as a pioneer in the Middle East for manufacturing complex generic drugs, particularly in the fields of oncology, neurology, and rare diseases. Their portfolio includes advanced therapies such as Capecitabine, Fingolimod, and Sorafenib, often being the first to produce these generic versions in the region. As a designated knowledge-based enterprise, the company focuses on high-value, low-volume pharmaceutical products, utilizing state-of-the-art GMP-compliant facilities to serve both domestic and international healthcare markets.